Cart
sales@molnova.com
WP1066
CAS No. 857064-38-1
WP1066( STAT Inhibitor III )
Catalog No. M16217 CAS No. 857064-38-1
WP1066 is a novel inhibitor of JAK2 and STAT3 with IC50 of 2.30 μM and 2.43 μM in HEL cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 46 | In Stock |
|
| 5MG | 42 | In Stock |
|
| 10MG | 70 | In Stock |
|
| 25MG | 126 | In Stock |
|
| 50MG | 209 | In Stock |
|
| 100MG | 293 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 714 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWP1066
-
NoteResearch use only, not for human use.
-
Brief DescriptionWP1066 is a novel inhibitor of JAK2 and STAT3 with IC50 of 2.30 μM and 2.43 μM in HEL cells.
-
DescriptionWP1066 is a novel inhibitor of JAK2 and STAT3 with IC50 of 2.30 μM and 2.43 μM in HEL cells; shows activity to JAK2, STAT3, STAT5, and ERK1/2 not JAK1 and JAK3. Phase 1.
-
In Vitro——
-
In Vivo——
-
SynonymsSTAT Inhibitor III
-
PathwayAngiogenesis
-
TargetJAK
-
RecptorJAK2| STAT3
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number857064-38-1
-
Formula Weight356.22
-
Molecular FormulaC17H14BrN3O
-
Purity>98% (HPLC)
-
SolubilityDMSO: 71 mg/mL (199.31 mM)
-
SMILESO=C(N[C@H](C1=CC=CC=C1)C)/C(C#N)=C/C2=NC(Br)=CC=C2
-
Chemical Name(S,E)-3-(6-bromopyridin-2-yl)-2-cyano-N-(1-phenylethyl)acrylamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Verstovsek S, et al. Clin Y Res, 2008, (3), 788-796.
molnova catalog
related products
-
Nimucitinib
Nimucitinib is a Janus kinase (JAK) inhibitor that can be used to treat dry eye and promote tear production.
-
WYE-151650
WYE-151650 is a novel potent, selective JAK3 inhibitor with IC50 of 0.8 nM, displays 36-, 14-, and 34-fold selectivity against JAK-1, JAK-2, and Tyk-2, respectively.
-
Ifidancitinib
Ifidancitinib (ATI-50002) is a specific JAK kinase 1/3 inhibitor that induces hair growth in AA-affected C3H/HeJ mice.Ifidancitinib can be used to study autoimmune diseases.
